GenFleet Therapeutics (Shanghai) Inc. (HKG:2595)

HKG:2595 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023
Period Ending	Feb 12, 2026	Dec 31, 2024	Dec 31, 2023
Debt / Equity Ratio	-0.04	-0.04	-0.02
Asset Turnover	-	0.18	-
Inventory Turnover	-	5.26	-
Quick Ratio	0.16	0.21	0.23
Current Ratio	0.17	0.23	0.25
Return on Assets (ROA)	-	-30.27%	-
Return on Capital Employed (ROCE)	6.20%	14.70%	22.10%
Buyback Yield / Dilution	-	-17.40%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.